Lexington, MA, United States of America

Xin Chen

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 12.2

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2015-2024

Loading Chart...
Loading Chart...
8 patents (USPTO):

Title: Innovations of Inventor Xin Chen

Introduction

Xin Chen is a prominent inventor based in Lexington, MA (US), known for his significant contributions to the field of pharmaceuticals. With a total of 8 patents to his name, he has made remarkable strides in developing innovative compounds that have potential therapeutic applications.

Latest Patents

Among his latest patents is the invention titled "Heteroaryl substituted spiropiperidinyl derivatives and pharmaceutical uses thereof." This invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof. Another notable patent is for "2-azaspiro[3.4]octane derivatives as M4 agonists." This patent details compounds according to Formula (I) or a pharmaceutically acceptable salt thereof, with specific definitions for R, R, R, R, and R. Additionally, it includes pharmaceutical compositions comprising a compound of Formula (I) and outlines the use of such compounds as M4 receptor agonists.

Career Highlights

Xin Chen has established a successful career at Novartis AG, where he continues to innovate and contribute to the pharmaceutical industry. His work focuses on developing new compounds that can lead to advancements in medical treatments.

Collaborations

Throughout his career, Xin has collaborated with several talented individuals, including Nancy Labbe-Giguere and Amy Calhoun. These collaborations have fostered a productive environment for innovation and research.

Conclusion

In summary, Xin Chen is a distinguished inventor whose work in pharmaceuticals has led to several important patents. His contributions continue to impact the field positively, showcasing the importance of innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…